Bayer to make $10.5 billion push to settle roundup cases, Bloomberg reports

BERLIN, Feb 17 (Reuters) - Bayer is planning to announce a $10.5 billion settlement push to settle ‌current and future cancer lawsuits over its ‌Roundup weedkiller, Bloomberg reported on Tuesday, citing people familiar with ​the plan.

Bayer did not immediately comment on the report.

The German chemical giant is set to propose a $7.5 billion class-action settlement through cases filed in state ‌court in Missouri ⁠designed to resolve Roundup suits that already have been filed and potential claims ⁠that could be filed over a 20-year period, Bloomberg reported.

Bayer is also preparing to announce $3 billion in ​settlements of ​existing U.S. cases ​in which former Roundup ‌users blame the herbicide for causing their non-Hodgkins lymphoma, it reported.

The company has paid about $10 billion to settle most of the Roundup lawsuits that were pending as of 2020, but failed to get ‌a settlement covering future cases. ​New lawsuits have continued to ​pour in since ​then. Plaintiffs have said they developed ‌non-Hodgkin's lymphoma and other forms ​of cancer ​due to using Roundup, either at home or on the job.

Roundup, which was acquired by ​is among ‌the most widely used weedkillers in the United ​States.

(Additional reporting by Kirsti KnolleWriting by Linda ​PasquiniEditing by Madeline Chambers)